Alergologia Polska - Polish Journal of Allergology
eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Share:
Share:

Functionality of the B.44 drug programme “Treatment of Patients with Severe Asthma” in 2025 from the perspective of medical centres

Marek Kulus
1
,
Karina Jahnz-Różyk
2
,
Radosław Gawlik
3
,
Maciej Kupczyk
4
,
Łukasz Skolimowski
5
,
Aleksander Junak
5
,
Anna Ben Drissi
5

  1. Department of Paediatric Pneumonology and Allergology, Medical University of Warsaw, Poland
  2. Department of Internal Medicine, Pneumonology, Allergology, Clinical Immunology and Rare Diseases, Military Medical Institute – National Research Institute, Warsaw, Poland
  3. Department of Internal Medicine, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland
  4. Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Poland
  5. Polish Society of Allergology, Coalition for Asthma Treatment, Lodz, Poland
Online publish date: 2026/03/20
Article file
Get citation
 
PlumX metrics:
 
1.
Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.


Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.